Researchers Submit Patent Application, "Method For Measuring Aggregating Proteins, Method For Visualizing Aggregation, And Kit Used Therefor", for Approval (USPTO 20240183865).

Researchers from Kaneka Corporation have developed a method for measuring and visualizing aggregating proteins, specifically amyloid beta proteins (Ab), which are associated with Alzheimer's disease. The method involves using a solution to accelerate and visualize protein aggregation, allowing for the collection and quantification of aggregating proteins. By removing contaminants and using a solution with a surface-active substance, the researchers were able to visualize the aggregates. This method has the potential to improve screening techniques for potential treatments for Alzheimer's disease. The patent application also describes kits containing the necessary materials for the method. [Extracted from the article]